BRIEF-AstraZeneca Reports Positive Phase III Results For PT010 In COPD

Jan 26 (Reuters) - AstraZeneca Plc:

* AZ REPORTS PHASE III RESULTS FOR PT010 IN COPD

* ‍PT010 DEMONSTRATES SIGNIFICANT IMPROVEMENT IN 8 OUT OF NINE LUNG FUNCTION PRIMARY ENDPOINTS COMPARED WITH DUAL COMBINATION THERAPIES​

* ‍THERE WERE NO UNEXPECTED SAFETY OR TOLERABILITY SIGNALS FOR PT010 IDENTIFIED IN TRIAL​ Source text for Eikon: Further company coverage: